BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 38473991)

  • 21. Natural Bioactive Compounds Targeting Epigenetic Pathways in Cancer: A Review on Alkaloids, Terpenoids, Quinones, and Isothiocyanates.
    El Omari N; Bakrim S; Bakha M; Lorenzo JM; Rebezov M; Shariati MA; Aboulaghras S; Balahbib A; Khayrullin M; Bouyahya A
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34835969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenethyl Isothiocyanate Induces Apoptosis Through ROS Generation and Caspase-3 Activation in Cervical Cancer Cells.
    Shoaib S; Tufail S; Sherwani MA; Yusuf N; Islam N
    Front Pharmacol; 2021; 12():673103. PubMed ID: 34393773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of artificial intelligence for detection of chemico-biological interactions associated with oxidative stress and DNA damage.
    Davidovic LM; Laketic D; Cumic J; Jordanova E; Pantic I
    Chem Biol Interact; 2021 Aug; 345():109533. PubMed ID: 34051207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzyl and phenethyl isothiocyanates as promising epigenetic drug compounds by modulating histone acetylation and methylation marks in malignant melanoma.
    Mitsiogianni M; Anestopoulos I; Kyriakou S; Trafalis DT; Franco R; Pappa A; Panayiotidis MI
    Invest New Drugs; 2021 Dec; 39(6):1460-1468. PubMed ID: 33963962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds.
    Haque A; Brazeau D; Amin AR
    Eur J Cancer; 2021 May; 149():165-183. PubMed ID: 33865202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EZH2 inhibition by tazemetostat: mechanisms of action, safety and efficacy in relapsed/refractory follicular lymphoma.
    Julia E; Salles G
    Future Oncol; 2021 Jun; 17(17):2127-2140. PubMed ID: 33709777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary isothiocyanates inhibit cancer progression by modulation of epigenome.
    Sundaram MK; R P; Haque S; Akhter N; Khan S; Ahmad S; Hussain A
    Semin Cancer Biol; 2022 Aug; 83():353-376. PubMed ID: 33434642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress and promises of epigenetic drugs and epigenetic diets in cancer prevention and therapy: A clinical update.
    Mondal P; Natesh J; Penta D; Meeran SM
    Semin Cancer Biol; 2022 Aug; 83():503-522. PubMed ID: 33309850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes.
    Scholze H; Stephenson RE; Reynolds R; Shah S; Puri R; Butler SD; Trujillo-Alonso V; Teater MR; van Besien H; Gibbs-Curtis D; Ueno H; Parvin S; Letai A; Mathew S; Singh A; Cesarman E; Melnick A; Giulino-Roth L
    Blood Adv; 2020 Oct; 4(20):5226-5231. PubMed ID: 33104794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulforaphane and iberin are potent epigenetic modulators of histone acetylation and methylation in malignant melanoma.
    Mitsiogianni M; Trafalis DT; Franco R; Zoumpourlis V; Pappa A; Panayiotidis MI
    Eur J Nutr; 2021 Feb; 60(1):147-158. PubMed ID: 32215717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tazemetostat: First Approval.
    Hoy SM
    Drugs; 2020 Apr; 80(5):513-521. PubMed ID: 32166598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The timeline of epigenetic drug discovery: from reality to dreams.
    Ganesan A; Arimondo PB; Rots MG; Jeronimo C; Berdasco M
    Clin Epigenetics; 2019 Dec; 11(1):174. PubMed ID: 31791394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining epigenetic drugs with other therapies for solid tumours - past lessons and future promise.
    Morel D; Jeffery D; Aspeslagh S; Almouzni G; Postel-Vinay S
    Nat Rev Clin Oncol; 2020 Feb; 17(2):91-107. PubMed ID: 31570827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Isothiocyanates as Cancer Chemo-Preventive, Chemo-Therapeutic and Anti-Melanoma Agents.
    Mitsiogianni M; Koutsidis G; Mavroudis N; Trafalis DT; Botaitis S; Franco R; Zoumpourlis V; Amery T; Galanis A; Pappa A; Panayiotidis MI
    Antioxidants (Basel); 2019 Apr; 8(4):. PubMed ID: 31003534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allyl isothiocyanate regulates lysine acetylation and methylation marks in an experimental model of malignant melanoma.
    Mitsiogianni M; Mantso T; Trafalis DT; Vasantha Rupasinghe HP; Zoumpourlis V; Franco R; Botaitis S; Pappa A; Panayiotidis MI
    Eur J Nutr; 2020 Mar; 59(2):557-569. PubMed ID: 30762097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal Antibodies for the Treatment of Melanoma: Present and Future Strategies.
    Bhandaru M; Rotte A
    Methods Mol Biol; 2019; 1904():83-108. PubMed ID: 30539467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Carcinogenic Glucosinolates in Cruciferous Vegetables and Their Antagonistic Effects on Prevention of Cancers.
    Soundararajan P; Kim JS
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30445746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation.
    Paul B; Li Y; Tollefsbol TO
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetics of malignant melanoma.
    Moran B; Silva R; Perry AS; Gallagher WM
    Semin Cancer Biol; 2018 Aug; 51():80-88. PubMed ID: 29074395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulforaphane Induced Apoptosis via Promotion of Mitochondrial Fusion and ERK1/2-Mediated 26S Proteasome Degradation of Novel Pro-survival Bim and Upregulation of Bax in Human Non-Small Cell Lung Cancer Cells.
    Geng Y; Zhou Y; Wu S; Hu Y; Lin K; Wang Y; Zheng Z; Wu W
    J Cancer; 2017; 8(13):2456-2470. PubMed ID: 28900483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.